Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An update from Wockhardt Limited ( (IN:WOCKPHARMA) ) is now available.
Wockhardt Limited has notified the stock exchanges that it has published a newspaper advertisement regarding a special SEBI-mandated window for re-lodgment of share transfer requests for shares held in physical form. The company has also made this advertisement available on its investor relations website and has asked the exchanges to take the disclosure on record, underscoring its compliance with updated securities transfer regulations.
The move facilitates shareholders who still hold physical share certificates to regularize or complete pending transfer requests during the special window period. This step is expected to improve transparency and ease of compliance for investors, while aligning Wockhardt with evolving market norms favoring dematerialized shareholding and tighter regulatory oversight.
More about Wockhardt Limited
Wockhardt Limited is an India-based pharmaceutical and biotechnology company focused on research-led manufacturing of generic and specialty medicines. The company serves domestic and international markets and is listed on both BSE and the National Stock Exchange under the symbol WOCKPHARMA, with a broad base of public shareholders.
Average Trading Volume: 41,088
Technical Sentiment Signal: Buy
Current Market Cap: 219.7B INR
See more data about WOCKPHARMA stock on TipRanks’ Stock Analysis page.